Commonwealth vs. yasipour
IN THE COURT OF COMMON PLEAS OF LYCOMING COUNTY, PENNSYLVANIA
COMMONWEALTH OF PENNSYLVANIA
Defendant : Motion to Suspend Medication
Before the Court is Defendant’s Motion to Suspend Administration of Medication, filed
February 3, 2006. A hearing on the motion was held February 15, 2006.
Defendant has been charged with homicide in connection with the killing of his five-
year-old daughter on August 24, 2001. Trial is scheduled to begin February 27, 2006. In the
instant motion, Defendant seeks to suspend the administration of the psychiatric medications
he has been taking since the entry of an Order in January 2005, requiring him to be
involuntarily medicated. Defendant contends the medication alters his normal emotional state,
suspension of the medication is necessary to show the jury his normal emotional state, and
denial of his request would violate his liberty interest in freedom from involuntary medication
and his due process right to a fair trial. The Commonwealth contends continued medication is
permissible to further an essential state interest.
In Riggins v. Nevada, 504 U.S. 127 (1992), the United States Supreme Court reiterated
previous holdings indicating that an individual does have a constitutionally protected liberty
interest in avoiding involuntary administration of anti-psychotic drugs, but went on to find that
such interest could be overcome by an overriding state interest. Specifically, the Court noted
that due process could be satisfied by a demonstration that treatment with anti-psychotic drugs
is medically appropriate and, considering less intrusive alternatives, is either essential for the
safety of the defendant or others, or necessary to render a defendant competent to stand trial.
In the instant case, the Commonwealth contends that continued medication is necessary to
prevent Defendant from becoming a danger to himself and/or others.
In support of their contention, the Commonwealth presented the testimony of
the prison psychiatrist, Dr. Terri Calvert, who has been involved with Defendant’s treatment
and has also reviewed the records of other treating physicians. Dr. Calvert testified that
Defendant is currently being administered risperdal, an anti-psychotic medication,1 as well as
wellbutrin, an anti-depressant. Both were prescribed in connection with the involuntary
treatment Order issued in January 2005, which Dr. Calvert indicated was necessary to address
certain self-injurious behaviors being engaged in by Defendant at that time. Specifically
Defendant was not taking his insulin (Defendant is diabetic) and was biting himself and
digging open the wounds, risking infection, especially in light of his diabetes. Defendant was
also drinking his own urine and smearing his feces on the walls of his cell and on himself.
Defendant was found to be a danger to himself, and there was a concern that he could die as a
result. When he returned to the county prison after having been at Warren State Hospital for a
period of time, Defendant’s condition was stabilized and he was much improved. The harmful
behaviors had ceased and Dr. Calvert indicated that it is very likely that the risperdal is a
significant reason for Defendant’s improvement. While Dr. Calvert questioned whether some
of Defendant’s behaviors had been merely attention-getting and not related to his psychosis,
she did indicate that to some extent, the improvement is connected to the administration of the
risperdal. In any event, Dr. Calvert emphatically stated that Defendant’s psychosis would
definitely worsen if the medication were to be discontinued, and that it would take at least a
As far as Defendant’s affect, which is the focus of his request to discontinue the
medication, Dr. Calvert indicated that the side effects of risperdal are fairly minimal and she
would not blame the risperdal for Defendant’s flat affect but, rather, the depression and stress
of the upcoming trial. Discontinuance of the wellbutrin would thus be counter-productive.
The Court therefore concludes the Commonwealth has shown that continuation of
Defendant’s current medications is medically appropriate and essential to prevent Defendant
from once again becoming a danger to himself. It is noted that the issue of less-intrusive
alternatives was not raised, and it appears that indeed the current medication is the least
intrusive method of treating Defendant effectively.
1 Defendant has been diagnosed with, inter alia, Schizophrenia.
AND NOW, this 21st day of February 2006, for the foregoing reasons, Defendant’s
Motion to Suspend Administration of Medication is hereby DENIED.
17. Silicones in Medical Applications X. Thomas, Dow Corning Europe SA, Seneffe (Belgium) Silicone materials celebrate 60 years of use in medical applications. Quickly after their commercial availability in 1946, methylchlorosilanes were described to treat glassware to prevent blood from clotting . At the same time, Dr. F. Lahey implanted a silicone elastomer tube for duct repair in bil
Cofnodion Cyfarfod Blynyddol Cyffredinol 25/09/2012 Annual General Meeting Minutes 01. Croeso/ Thank you to all parents and teachers who attended the meeting. 02. Presennol ymddiheuriadau/ Present and Apologies Ymddiheuriadau / Apologies: 03. Cofnodion y Derbyniwyd cofnodion y cyfarfod diwethaf (08/05/2012) Minutes of the last meeting (08/05/2012) were accepted